Member Info for bigsmoke

Are we there yet?

Is the nom value not 2p? so, no raise at 1p.

sub placing SP - yum..

.

Run that by me...

they have exercised their options and paid 6p and can now sell for c. 12p. And you think that's good?

What else did the t leaves say?

"In effect the warrant holders could buy at 2p and sell at 20."

and now they cannot.

I assume you were going long when it was clear they could?

Was just saying..

Sorry, misread - not 9p, nearly 12p!

For those going long on CTL, shows you might want to look at carrying MET1 also.

"The majority of Placing Shares were placed with current institutional long-term investors, existing shareholders and some new investors who recognise the long-term value proposition of the Company given its position in Chile at present and a changing sentiment in the market for lithium plays."

"The majority of Placing Shares were placed with current institutional long-term investors, existing shareholders and some new investors who recognise the long-term value proposition of the Company given its position in Chile at present and a changing sentiment in the market for lithium plays."

"Metals One ... was approached to sell, and has completed the sale of, a block of 7,000,000 shares in CleanTech Lithium (AIM: CTL, Frankfurt:T2N) for £0.910 million representing approximately a 159% profit on the Company's weighted average share purchase price. Metals One's made its first investment in CleanTech Lithium in August 2025. Following the sale, Metals One holds 5,850,000 shares in CleanTech Lithium, representing approximately 2.88% of CleanTech Lithium's issued share capital, in addition to 20,000,000 warrants with an exercise price of 6 pence expiring in August 2030 (CleanTech Lithium share price as at market close on 13 March 2026: 11.75p)."

So, rinse and repeat?

Sold "£0.910" - i assume 9p and not 91p - which would be extraordinary. And back in at 6p?

Not bad for three months work?

I assume MET1 have topped up at 6p?

Exercise of Options and Total Voting Rights

Metals Exploration PLC (AIM: MTL) ("Metals Exploration" or the "Company"), a gold producer, development and exploration company with assets in the Philippines and Nicaragua, announces that it has received notices of exercise of options in respect of 6,099,128 new ordinary shares of £0.0001 each ("Ordinary Shares"), with an average exercise price of £0.0665 each, raising a total of £405,750.56.

Admission and Total Voting Rights

Application has been made to the London Stock Exchange PLC for the admission of 6,099,128 new Ordinary Shares to trading on AIM ("Admission"), which is expected to take place at 8.00 a.m. on or around 9 June 2026.

Following Admission, the Company will have 3,285,555,158 Ordinary Shares in issue, of which 299,385,458 Ordinary Shares are held in treasury, and, accordingly, the total number of voting rights is 2,986,169,700. Therefore, this figure may be used by shareholders in the Company as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Rns

Receipt of R&D tax credit

genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, confirms it has received an R&D tax credit refund of approximately £0.76m from HMRC in respect of the financial years ended 30 June 2024 and 30 June 2025.

Rns

Nm.

Posting of Annual Report & Notice of Annual General Meeting

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group, confirms that the Annual Report and Accounts for the year ended 31 December 2025, the Notice of the Annual General Meeting ("AGM") and a Form of Proxy will be posted to shareholders today and will shortly be available on the Company's website at https://hemogenyx.com/investors/annual-half-year-reports/.

The AGM is to be held on 30 June 2026 at 2.00 pm BST at One Heddon Street, London, W1B 4BD.

Out

Didnt quite get off the blocks today.